-
Mashup Score: 4
Purpose of Review To provide an updated review of bempedoic acid’s clinical application in lowering LDL-C in the setting of statin intolerance and the recent findings in the CLEAR Outcomes trial as well as summarize and synthesize the current state of knowledge regarding bempedoic acid while providing an in-depth analysis of the drug’s pharmacological properties, mechanism of action, clinical…
Source: SpringerLinkCategories: Cardiology News and Journals, Latest HeadlinesTweet
-
Mashup Score: 0The NACE Clinical Highlights Show: The NACE Journal Club with Dr. Neil Skolnik - #3 on Apple Podcasts - 1 year(s) ago
Show The NACE Clinical Highlights Show, Ep The NACE Journal Club with Dr. Neil Skolnik – #3 – Mar 22, 2023
Source: Apple PodcastsCategories: Cardiologists, Latest HeadlinesTweet-
I enjoyed doing this podcast with @NeilSkolnik for @NACECMEOnline discussing #ClearOutomes and the role of #BempedoicAcid in #Lipid managment #Lipids @NYUCVDPrevent @nationallipid @Drlipid https://t.co/Ra8gFVk4Rm https://t.co/N6uxHW9dDp https://t.co/eqphWBJmRm
-
-
Mashup Score: 2
Show This Week in Cardiology, Ep Mar 10 2023 This Week in Cardiology – 10 Mar 2023
Source: Apple PodcastsCategories: Hem/Oncs, Latest HeadlinesTweet-
RT @MarkNaunton: This week’s episode is gold . Agree w @drjohnm re #bempedoicacid . https://t.co/n8KRyonEtL
-
-
Mashup Score: 0
March 4, 2023 — The cholesterol-lowering drug bempedoic acid was found to reduce the combined rate of major adverse cardiovascular events by 13%, meeting its primary endpoint in a large study of patients with high cholesterol who were unable to tolerate statins, according to research reported on during the American College of Cardiology’s Annual Scientific Session Together with the World Congress…
Source: DAICCategories: Cardiologists, Latest HeadlinesTweet-
@DAICeditor @EsperionInc Results of the #CLEAR Outcomes trial presented at #Acc23 #wcc23 found #BempedoicAcid lowered #cholesterol and reduced the risk of serious cardiovascular outcomes in #statin-intolerant patients: https://t.co/fcuIqAgLTE
-
-
Mashup Score: 4
Further LDL-C reductions through the addition of BA+EZE FDC to maximally tolerated statins are predicted to reduce major adverse cardiovascular events compared with the addition of EZE. Benefits are potentially greater among those with higher starting LDL-C.
Source: PubMedCategories: Cardiologists, Latest HeadlinesTweet-
Potential Cardiovascular Events Avoided with #BempedoicAcid #Ezetimibe Fixed-Dose Combination Compared with Eze alone #lipids https://t.co/5X3IUfLZXV
-
-
Mashup Score: 1
The cholesterol benefits of bempedoic acid plus background therapy were consistent across subgroups of patients with hypertension, metabolic syndrome and renal impairment, researchers reported.At the National Lipid Association (NLA) Scientific Sessions, researchers presented three substudies of the CLEAR trials that evaluated the efficacy and safety of bempedoic acid (Nexletol, Esperion
Source: www.healio.comCategories: Cardiologists, Latest HeadlinesTweet-
#BempedoicAcid #lipids https://t.co/NMRl4J7LKC
-
-
Mashup Score: 1James Underberg on LinkedIn: Lipid lowering with bempedoic acid added to a proprotein convertase - 3 year(s) ago
Amazing and Impressive: Bempedoic acid, when added to background PCSK9 inhibitor therapy, lowered LDL-C by 30.3% vs placebo in a double blind randomized…
Source: www.linkedin.comCategories: Cardiologists, Latest HeadlinesTweet-
#BempedoicAcid, when added to background #PCSK9 inhibitor therapy, lowered LDL-C by 30.3% vs placebo in a double blind randomized trial. Via @LipidJournal National Lipid Association https://t.co/ZTPpUZZ7ue
-
-
Mashup Score: 7Bempedoic Acid (Nexletol) for the Treatment of Hyperlipidemia and Familial Hypercholesterolemia - PubMed - 3 year(s) ago
Bempedoic Acid (Nexletol) for the Treatment of Hyperlipidemia and Familial Hypercholesterolemia
Source: PubMedCategories: Cardiologists, Latest HeadlinesTweet-
RT @SABOURETCardio: #BempedoicAcid (Nexletol) for the Treatment of Hyperlipidemia and Familial #Hypercholesterolemia https://t.co/zzp8MrnNEz
-
-
Mashup Score: 10
The profile of bempedoic acid from its design,development,& its place in therapy for the management of LDL-C for the purposes of ASCVD prevention is dicussed.
Source: www.dovepress.comCategories: Cardiologists, Latest HeadlinesTweet-
Congrats to @AAgarwalaMD for leading this excellent review on #BempedoicAcid in #KnowFH from Bench to Bedside, with help from @rquispe183 and Dr Anne Goldberg in Drug Design, Development and Therapy journal. #lipids #cvPrev 👏👏👏 https://t.co/qEWdRT4pKr https://t.co/9pqeaLY8ZS
-
-
Mashup Score: 5Bempedoic Acid (Nexletol) for the Treatment of Hyperlipidemia and Familial Hypercholesterolemia - PubMed - 3 year(s) ago
Bempedoic Acid (Nexletol) for the Treatment of Hyperlipidemia and Familial Hypercholesterolemia
Source: PubMedCategories: Cardiologists, Latest HeadlinesTweet-
#BempedoicAcid (Nexletol) for the Treatment of Hyperlipidemia and Familial #Hypercholesterolemia https://t.co/zzp8MrnNEz
-
👇 Check it out! Here’s an up-to-date review on Bempedoic acid and all the latest trials: https://t.co/iF1svkaDdd. #cholesterol #LDL #bempedoicacid #statin #myalgias #CLEAROutcomes #prevention #cardiology